Loading...
XSHG600062
Market cap2.70bUSD
Jan 17, Last price  
19.44CNY
1D
1.53%
1Q
-15.95%
Jan 2017
24.87%
Name

China Resources Dubl-Crne Phrmctl Co Ltd

Chart & Performance

D1W1MN
XSHG:600062 chart
P/E
14.96
P/S
1.95
EPS
1.30
Div Yield, %
1.51%
Shrs. gr., 5y
-0.35%
Rev. gr., 5y
4.44%
Revenues
10.22b
+8.21%
4,195,715,4484,597,428,9994,049,090,0234,556,616,3814,951,524,3675,037,946,4175,366,795,8116,383,375,2756,989,323,4086,834,574,3254,280,960,9545,138,395,4015,494,803,8696,421,846,7688,225,083,3139,380,989,9278,503,938,2299,111,516,9309,446,925,26710,222,132,107
Net income
1.33b
+12.96%
4,705,283186,639,285164,893,391437,580,763380,572,486451,456,597520,094,650528,998,582614,408,188870,690,215541,907,853661,063,516714,210,861842,612,497968,593,3871,055,123,7081,005,161,634935,685,4821,180,062,4121,333,029,471
CFO
1.65b
+23.04%
453,715,358139,775,069303,708,790235,458,162331,710,145342,013,845509,674,695511,526,104396,048,302546,240,145718,376,437701,346,759771,247,8221,187,087,9901,469,039,6311,439,788,4701,360,158,2101,340,920,9631,341,669,6481,650,775,992
Dividend
Jul 15, 20240.257 CNY/sh
Earnings
May 16, 2025

Profile

China Resources Double-Crane Pharmaceutical Co.,Ltd., together with its subsidiaries, operates as a pharmaceutical company in the People's Republic of China. The company offers soft bag, plastic and glass bottle, inner sealed polypropylene, and polypropylene blend bag infusion products; levofloxacin methylate, ambroxol hydrochloride glucose, fructose, invert sugar, hydroxyethyl starch, sodium chloride injection products, etc.; and peritoneal dialysate, hemodialysis dialysate, etc. It also provides compound reserpine triamterene tablets, pitavastatin calcium tablets, telmisartan capsules, suppository capsules, banidipine hydrochloric acid sustained-release capsules, edaravone, and other products to treat cardiovascular and cerebrovascular diseases. In addition, the company offers products for endocrinology; and pediatric compound amino acid injection, and other drugs to treat pediatrics. Further, it provides nutritional drugs, including vitamin E and C; and anti-infective drugs. The company is headquartered in Beijing, the People's Republic of China. China Resources Double-Crane Pharmaceutical Co.,Ltd. is a subsidiary of Beijing Pharmaceutical Group Co., Ltd.
URL
https://www.dcpc.com/
IPO date
May 22, 1997
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
10,222,132
8.21%
9,446,925
3.68%
Cost of revenue
7,213,852
7,493,643
Unusual Expense (Income)
NOPBT
3,008,280
1,953,282
NOPBT Margin
29.43%
20.68%
Operating Taxes
240,615
199,256
Tax Rate
8.00%
10.20%
NOPAT
2,767,666
1,754,026
Net income
1,333,029
12.96%
1,180,062
26.12%
Dividends
(300,485)
(799,188)
Dividend yield
1.58%
4.31%
Proceeds from repurchase of equity
(30,733)
(146,177)
BB yield
0.16%
0.79%
Debt
Debt current
29,969
32,060
Long-term debt
59,899
265,864
Deferred revenue
198,801
Other long-term liabilities
291,765
149,395
Net debt
(3,723,787)
(2,682,616)
Cash flow
Cash from operating activities
1,650,776
1,341,670
CAPEX
(604,470)
Cash from investing activities
(707,765)
666,783
Cash from financing activities
(358,321)
FCF
2,648,770
1,033,540
Balance
Cash
3,457,023
2,830,737
Long term investments
356,632
149,803
Excess cash
3,302,549
2,508,194
Stockholders' equity
11,789,773
10,905,322
Invested Capital
8,838,907
8,632,931
ROIC
31.68%
21.70%
ROCE
24.46%
17.28%
EV
Common stock shares outstanding
1,025,250
1,035,506
Price
18.60
3.97%
17.89
33.81%
Market cap
19,069,642
2.94%
18,525,199
32.82%
EV
16,045,216
16,549,617
EBITDA
3,658,485
2,493,865
EV/EBITDA
4.39
6.64
Interest
2,824
10,625
Interest/NOPBT
0.09%
0.54%